1. Home
  2. |Insights
  3. |Let’s Talk All Things MoCRA – Is Your Company Prepared?

Let’s Talk All Things MoCRA – Is Your Company Prepared?

Webinar | 06.11.24, 1:00 PM EDT - 2:00 PM EDT

Address

Virtual

Watch the On-Demand Program Here

The FDA will begin to enforce the Modernization of Cosmetics Regulation Act (MoCRA)’s facility and product registration requirements on July 1, 2024. MoCRA has a significant impact on U.S. cosmetic manufacturers and marketers (and suppliers of ingredients). Companies should initiate steps to implement compliant systems now. Is your company prepared? To help make sure you are ready for these new requirements, Crowell & Moring is offering a webinar to discuss MoCRA and describe the key requirements under this law. During this webinar, panelists from Crowell’s Beauty and Wellness team (Robbie Jost, Helen Ogunyanwo, and Julia Carbonetti) and Marcha Isabelle Chaudry (Founder of Equity & Wellness Collaborative) will discuss:

  • The statutory obligations under MoCRA 
  • Who is Responsible for what and when
  • What companies should do to comply

Please contact Tricia Wyse with any quesitons.

For more information, please visit these areas: Mass Tort, Product and Consumer Litigation, Product Risk Management, Advertising and Brand Protection

Participants

Insights

Webinar | 10.16.25

The Artificial Intelligence Agenda from Capitol Hill to State Capitals: Where We Are and Where We Are (Probably) Going

The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:...

View All Insights